Birmingham Internal Medicine Associates, LLC
Birmingham Internal Medicine Associates, LLC was paid $2.70M by Medicaid between Sep 2020 and Dec 2024, across 110 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoBIRMINGHAM INTERNAL MEDICINE ASSOCIATES, LLC
BIRMINGHAM, AL 35242
BIRMINGHAM, AL 35242
33aNPI1598796542assigned 07/06/2006
33bProvider typeRegistered Dietitian
28Total paid$2.70M
24GClaims130,657
24DCodes billed110
24AFirst – last monthSep 2020 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,312 | $25K | |
| 2021 | 29,278 | $423K | |
| 2022 | 44,552 | $1.30M | |
| 2023 | 25,579 | $565K | |
| 2024incomplete | 28,936 | $393K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 19,515 | 17,172 | $950K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 15,179 | 12,731 | $916K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.6% | 3,136 | 2,860 | $124K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.6% | 1,016 | 1,001 | $69K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 1,018 | 989 | $68K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 4,424 | 2,853 | $47K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 606 | 595 | $42K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 3,810 | 3,467 | $41K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 4,637 | 3,344 | $32K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 451 | 449 | $31K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.1% | 1,341 | 1,240 | $31K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.1% | 364 | 308 | $29K |
98 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,983 | $25K |
| 90686 | <1% | 1,145 | $20K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 2,302 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 956 | $20K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 302 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,733 | $17K |
| 80061 | Lipid panel | <1% | 1,276 | $16K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 925 | $16K |
| 80053 | Comprehensive metabolic panel | <1% | 1,142 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 753 | $11K |
| 81003 | <1% | 3,828 | $11K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 221 | $10K |
| 80076 | <1% | 1,420 | $10K | |
| 84481 | <1% | 686 | $10K | |
| 90670 | <1% | 426 | $7K | |
| 99173 | <1% | 1,404 | $7K | |
| 84439 | <1% | 712 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 529 | $6K |
| 90648 | <1% | 311 | $5K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 350 | $5K |
| 0072A | <1% | 130 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 249 | $5K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 112 | $4K |
| 0071A | <1% | 105 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 31 | $3K |
| 99051 | <1% | 170 | $3K | |
| 90680 | <1% | 145 | $3K | |
| 93000 | <1% | 152 | $3K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 43 | $2K |
| 90651 | <1% | 118 | $2K | |
| H1000 | Prenatal care, at-risk assessment | <1% | 25 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,504 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 129 | $2K |
| 90756 | <1% | 73 | $2K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 83 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 69 | $2K |
| 90723 | <1% | 88 | $1K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 127 | $1K |
| 90461 | <1% | 28 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 54 | $1K |
| 99460 | <1% | 16 | $1K | |
| 83655 | <1% | 87 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 18 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,376 | $1K |
| 90633 | <1% | 78 | $1K | |
| 90710 | <1% | 69 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 27 | $944.17 |
| 82607 | <1% | 60 | $918.19 | |
| 85027 | <1% | 209 | $820.83 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 20 | $785.85 |
| 90671 | <1% | 34 | $672.86 | |
| 90674 | <1% | 24 | $649.23 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $614.00 |
| 90696 | <1% | 37 | $602.54 | |
| 0003A | <1% | 14 | $560.00 | |
| 87807 | <1% | 46 | $484.00 | |
| 82746 | <1% | 38 | $454.54 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 76 | $380.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 207 | $345.08 |
| 90734 | <1% | 14 | $277.06 | |
| 90744 | <1% | 13 | $257.27 | |
| 81001 | <1% | 81 | $256.00 | |
| 80047 | <1% | 25 | $200.66 | |
| 87210 | <1% | 38 | $185.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 16 | $160.00 |
| 87070 | <1% | 14 | $154.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $149.60 |
| 80305 | <1% | 18 | $146.58 | |
| 96127 | <1% | 41 | $134.07 | |
| 81025 | <1% | 47 | $114.00 | |
| 90700 | <1% | 12 | $96.00 | |
| 90698 | <1% | 15 | $96.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 43 | $73.24 |
| 87220 | <1% | 12 | $36.00 | |
| 1160F | 0% | 4,310 | $0.00 | |
| 1159F | 0% | 4,579 | $0.00 | |
| 3078F | 0% | 6,410 | $0.00 | |
| 99499 | 0% | 1,466 | $0.00 | |
| 3077F | 0% | 182 | $0.00 | |
| 4025F | 0% | 280 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 18 | $0.00 |
| 99080 | 0% | 163 | $0.00 | |
| 3028F | 0% | 87 | $0.00 | |
| 3074F | 0% | 7,600 | $0.00 | |
| 1125F | 0% | 1,657 | $0.00 | |
| 3079F | 0% | 1,311 | $0.00 | |
| 3008F | 0% | 12,347 | $0.00 | |
| 1036F | 0% | 401 | $0.00 | |
| 1126F | 0% | 3,938 | $0.00 | |
| 3080F | 0% | 16 | $0.00 | |
| 1034F | 0% | 36 | $0.00 | |
| 3044F | 0% | 308 | $0.00 | |
| 3075F | 0% | 198 | $0.00 | |
| 99000 | 0% | 42 | $0.00 | |
| 2000F | 0% | 59 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 15 | $0.00 |
| 1000F | 0% | 18 | $0.00 | |
| 4010F | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFARLEY, JOHN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Farley Dental Care LLC | South Point, OH | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.